Marshall Wace’s Bausch Health BHC Stock Holding History

Marshall Wace’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-300,500	Closed	-$2.4M	–	2201
2023 Q2	$2.4M	Buy	+300,500	New	+$2.22M	﹤0.01%	1315

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace's BHC Position: Q1 2026 in Review

Marshall Wace sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 604,481 shares — an estimated $4.2M sold.

Marshall Wace first reported a position in BHC in Q1 2014 and held it in 22 quarters. The position peaked at $29.4M in Q2 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Marshall Wace reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
Marshall Wace sold 604,481 Bausch Health shares in Q1 2026, an estimated $4.2M.
Marshall Wace first reported a position in Bausch Health in Q1 2014 and held it in 22 quarters.
Marshall Wace's Bausch Health position peaked at $29.4M in Q2 2015.
227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.